Peptide Discovery
Delivering Peptide Discovery Solutions
Learn More
What We Do
Orbit Discovery provides peptide discovery services for therapeutic applications, including radionuclide targeting, nucleic acid targeting, targeted protein degradation, soluble protein targeting and GPCR agonism and antagonism.

We combine our bead-based display system and microfluidics to perform high-throughput screening across very large chemical spaces, including both linear and macrocyclic peptide development.

Our services are customizable for both affinity screening (targeting binders) and direct functional screening (especially for agonism and antagonism) using proprietary reporter cell lines.

Our mission is to help partners identify peptide therapeutic hits through advanced high-throughput affinity and functional screening techniques.

The Orbit Display Bead:
Peptide and Encoding DNA: Linked

Applications
Our Platform
Learn More

Latest Updates

Orbit Discovery to Attend BioEurope Spring 2026 in Lisbon
December 10, 2026

Orbit Discovery to attend BioEurope Spring in March 2026

Orbit Discovery to Attend PepTalk 2026 in January
December 10, 2025

Orbit Discovery to Attend PepTalk 2026 in San Diego in January

Orbit Discovery to Attend Biotech Showcase at JPM 2026
December 10, 2025

Orbit Discovery is heading to the Biotech Showcase at JPM 2026 in January

Work With Us
Orbit Discovery work with Big Pharma and
Small Biotechs alike.

Find out how Orbit Discovery can help with your peptide discovery needs
Contact Us